ROCKET PHARMACEU

RCKT NASDAQ
12.53
-0.46
-3.54%
After Hours: 12.53 0 0.00% 17:04 07/19 EDT
Open
13.00
Prev Close
12.99
High
13.24
Low
12.50
Volume
289.40K
Avg Vol (3M)
395.22K
52 Week High
25.96
52 Week Low
10.75
% Turnover
0.58%
Market Cap
630.13M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ROCKET PHARMACEU RCKT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.
MORE >

Recently

Name
Price
%Change